Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial

Background: Clostridium difficile infection (CDI) is a recent epidemic in the United States, particularly in the hospital setting. Oral metronidazole is standard therapy for C. difficile infection, but resistance to metronidazole is becoming a clinical challenge. Methods: We evaluated the efficacy o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Patrick Basu, P., Dinani, Amreen, Rayapudi, Krishna, Pacana, Tommy, Shah, Niraj James, Hampole, Hemant, Krishnaswamy, N. V., Mohan, Vinod
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2010
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002581/
https://ncbi.nlm.nih.gov/pubmed/21180604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X10372985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados